Lymphoproliferative syndrome is characterized by a persistance of stimmulated lymphocytes as apoptosis of these cells is defective. The disorder is characterized by non-malignant accumulation of lymphocytes in various tissues which may induce secodary atoimmune reactions and cancer.
| 1. |
Sullivan JL et al. (1983) X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
|
| 2. |
Skare JC et al. (1989) Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq.
|
| 3. |
Skare JC et al. (1989) Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37.
|
| 4. |
Harris A et al. (1988) X-linked lymphoproliferative disease: a karyotype analysis.
|
| 5. |
Skare JC et al. (1987) Mapping the X-linked lymphoproliferative syndrome.
|
| 6. |
Harris A et al. (1988) X-linked lymphoproliferative disease: linkage studies using DNA probes.
|
| 7. |
Loeffel S et al. (1985) Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome.
|
| 8. |
Hayoz D et al. (1988) X-linked lymphoproliferative syndrome. Identification of a large family in Switzerland.
|
| 9. |
Steinherz R et al. (1985) X-linked lymphoproliferative syndrome. A new kindred with variable phenotypic expression.
|
| 10. |
Bar RS et al. (1974) Fatal infectious mononucleosis in a family.
|
| 11. |
Hambleton G et al. (1969) Familial lymphoma.
|
| 12. |
Lyon MF et al. (1983) X-linked factor in acquired immunodeficiency syndrome?
|
| 13. |
Sullivan JL et al. (1980) Deficient natural killer cell activity in x-linked lymphoproliferative syndrome.
|
| 14. |
Purtilo DT et al. (1982) Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry.
|
| 15. |
Sanger WG et al. (1990) Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP)
|
| 16. |
None (1981) X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
|
| 17. |
Levine PH et al. (1982) The American Burkitt's Lymphoma Registry: eight years' experience.
|
| 18. |
Hamilton JK et al. (1980) X-linked lymphoproliferative syndrome registry report.
|
| 19. |
Williams LL et al. (1993) Correction of Duncan's syndrome by allogeneic bone marrow transplantation.
|
| 20. |
Vowels MR et al. (1993) Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells.
|
| 21. |
Grierson HL et al. (1993) Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).
|
| 22. |
Skare J et al. (1993) Characterization of three overlapping deletions causing X-linked lymphoproliferative disease.
|
| 23. |
Seemayer TA et al. (1995) X-linked lymphoproliferative disease: twenty-five years after the discovery.
|
| 24. |
Arkwright PD et al. (1998) X linked lymphoproliferative disease in a United Kingdom family.
|
| 25. |
Dutz JP et al. (2001) Lymphocytic vasculitis in X-linked lymphoproliferative disease.
|
| 26. |
Ma CS et al. (2006) Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease.
|
| 27. |
Verhelst H et al. (2007) Limbic encephalitis as presentation of a SAP deficiency.
|
| 28. |
Booth C et al. (2011) X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
|
| 29. |
Sneller MC et al. (1997) Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
|
| 30. |
Rigaud S et al. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
|
| 31. |
Worthey EA et al. (2011) Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease.
|
| 32. |
Yang X et al. (2012) Clinical and genetic characteristics of XIAP deficiency in Japan.
|
| 33. |
Latour S et al. (2015) XIAP deficiency syndrome in humans.
|
| 34. |
Dziadzio M et al. (2015) Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.
|
| 35. |
Nishida N et al. (2015) Dysgammaglobulinemia Associated With Glu349del, a Hypomorphic XIAP Mutation.
|
| 36. |
Coffey AJ et al. (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.
|
| 37. |
Sumegi J et al. () The molecular genetics of X-linked lymphoproliferative (Duncan's) disease.
|
| 38. |
Brandau O et al. (1999) Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
|
| 39. |
Nichols KE et al. (2005) Regulation of NKT cell development by SAP, the protein defective in XLP.
|
| 40. |
Snow AL et al. (2009) Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.
|
| 41. |
Wang J et al. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
|
| 42. |
Zhu S et al. (2006) Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
|
| 43. |
Ma CS et al. (2005) Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.
|
| 44. |
Zhao M et al. (2010) A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly.
|
| 45. |
Pachlopnik Schmid J et al. (2011) Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
|
| 47. |
Purtilo DT et al. (1975) X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).
|
| 48. |
None (1976) Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome.
|
| 49. |
Purtilo DT et al. (1978) Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome.
|
| 50. |
Provisor AJ et al. (1975) Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children.
|
| 51. |
Purtilo DT et al. (1977) Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.
|
| 52. |
Purtilo DT et al. (1977) Hematopathology and Pathogenesis of the X-linked recessive lymphoproliferative syndrome.
|
| 53. |
Skare J et al. (1992) First prenatal diagnosis of X-linked lymphoproliferative disease.
|
| 54. |
Mulley JC et al. (1992) X-linked lymphoproliferative disease: prenatal detection of an unaffected histocompatible male.
|
| 55. |
Purtilo DT et al. (1991) Methods of detection of new families with X-linked lymphoproliferative disease.
|